
Caprolactam Chemicals Ltd Downgraded to Sell Amid Technical Weakness and Fundamental Concerns
2026-07-28 08:23:44Caprolactam Chemicals Ltd, a micro-cap player in the commodity chemicals sector, has seen its investment rating downgraded from Hold to Sell as of 27 July 2026. This shift reflects a deterioration in technical indicators alongside mixed financial performance and valuation concerns, prompting a reassessment of the stock’s attractiveness for investors.
Read full news article
Caprolactam Chemicals Ltd Upgraded to Hold on Improved Technicals and Financial Performance
2026-07-23 08:13:43Caprolactam Chemicals Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and robust quarterly financial results. The upgrade, effective from 22 July 2026, is driven by a combination of enhanced technical trends, strong financial growth, attractive valuation metrics, and a stabilising quality outlook amid a challenging commodity chemicals sector.
Read full news articleAre Caprolactam Chemicals Ltd latest results good or bad?
2026-05-31 19:20:41Caprolactam Chemicals Ltd has reported its financial results for the quarter ended March 2026, showcasing a notable operational turnaround. The company achieved net sales of ₹3.07 crores, reflecting a year-on-year growth of 90.68% and a quarter-on-quarter increase of 19.92%. This significant revenue growth indicates a recovery trajectory following previous challenges. The net profit for the quarter stood at ₹0.84 crores, marking a return to profitability compared to a loss in the same quarter last year. This represents a substantial improvement in the company's financial health. The operating margin reached 54.07%, the highest in eight quarters, demonstrating effective cost management and operational efficiency. Additionally, the profit after tax (PAT) margin improved to 27.36%, a stark contrast to the negative margin reported in the previous year. Despite these positive operational metrics, Caprolactam C...
Read full news article
Caprolactam Chemicals Q4 FY26: Turnaround Gains Momentum but Valuation Concerns Persist
2026-05-30 23:47:51Caprolactam Chemicals Ltd., a micro-cap commodity chemicals manufacturer with a market capitalisation of ₹22.00 crores, reported a remarkable turnaround in Q4 FY26 (January-March 2026), posting net profit of ₹0.84 crores compared to a loss of ₹0.45 crores in the same quarter last year. The stock has responded positively to the operational recovery, gaining 18.60% over the past year, though it remains 39.46% below its 52-week high of ₹81.00. At the current market price of ₹49.04, the company trades at a concerning valuation of 2,254 times trailing twelve-month earnings, raising serious questions about sustainability despite improved fundamentals.
Read full news articleAre Caprolactam Chemicals Ltd latest results good or bad?
2026-05-30 19:43:41Caprolactam Chemicals Ltd's latest financial results for Q2 FY26 present a mixed picture, highlighting both revenue growth and significant challenges in profitability. The company reported net sales of ₹2.36 crores, which reflects a sequential decline of 7.81% from the previous quarter but shows a year-on-year growth of 38.01% compared to ₹1.71 crores in the same quarter last year. This indicates that while the company is experiencing some demand traction, it is also facing potential softness in order flows or seasonal factors affecting sales. On the profitability front, net profit for the quarter was ₹0.13 crores, marking a substantial quarter-on-quarter decline of 63.89% from ₹0.36 crores in Q1 FY26. However, this represents a notable improvement from the ₹0.04 crores profit recorded in the same quarter last year. The operating margin also contracted significantly to 27.97%, down from 40.63% in the previ...
Read full news article
Caprolactam Chemicals Ltd Downgraded to Strong Sell Amid Technical and Fundamental Weaknesses
2026-05-28 08:13:28Caprolactam Chemicals Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 27 May 2026, driven primarily by deteriorating technical indicators and stagnant financial performance. Despite a modest one-year stock return outperforming the broader market, the company’s weak fundamentals and bearish technical trends have raised concerns among analysts and investors alike.
Read full news article
Caprolactam Chemicals Ltd is Rated Sell
2026-05-15 10:10:02Caprolactam Chemicals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
02-Jul-2026 | Source : BSECompliance Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations 2018
Closure of Trading Window
25-Jun-2026 | Source : BSEClosure of Trading Window
Announcement under Regulation 30 (LODR)-Newspaper Publication
01-Jun-2026 | Source : BSENewspaper Advertisement of the Audited Financial Result for Quarter ended 31 March 2026
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






